Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061378) titled 'A Study of a New Three-Dimensional Method to Measure Hand and Finger Movements After Stroke' on April 27.

Study Type: Observational

Primary Sponsor: Institute - Keio University School

Condition: Condition - stroke Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The aim of this study is to develop an assessment method using the extended version of Google MediaPipe Hands (GMH-D) to quantitatively evaluate three-dimensional finger positions in patients with post-stroke motor paralysis, and to examine its reliability, validity, and responsiveness. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old

Gender - Male and Female Key inclusion criteria - 1. Age 18 years or older. For the prospective cohort study assessing responsiveness, only first-ever stroke patients will be included. 2. Unilateral cerebral lesion confirmed by imaging findings or physician diagnosis/clinical records. 3. Ability to position the hand so that the fingertips can be captured by the camera during assessment. Key exclusion criteria - 1.Severe finger contracture or spasticity affecting the hand/fingers. 2.Difficulty in communication due to aphasia or impaired consciousness. 3.Severe higher brain dysfunction that interferes with assessment procedures. 4.Severe visual or hearing impairment. 5.Severe psychiatric disorders such as depression or schizophrenia. 6.Contraindications to exercise therapy, including: a. Severe cardiovascular disease, such as unstable angina, recent myocardial infarction, decompensated congestive heart failure, acute cor pulmonale, uncontrolled arrhythmia, severe aortic stenosis, active myocarditis, or endocarditis. b. Uncontrolled hypertension. c. Acute systemic illness or fever. d. Recent pulmonary embolism, acute cor pulmonale, or severe pulmonary hypertension. e. Severe hepatic or renal dysfunction. f. Severe orthopedic disorders interfering with exercise. g. Severe cognitive impairment or severe psychiatric disorders. h. Other metabolic disorders (e.g., acute thyroiditis). Target Size - 125

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 03 Month 30 Day Anticipated trial start date - 2026 Year 04 Month 27 Day Last follow-up date - 2029 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070123

Disclaimer: Curated by HT Syndication.